Antigen Specificity in Subsets of Mucous Membrane Pemphigoid

Mucous membrane pemphigoid (MMP) has several subsets based on target antigens recognized by their sera. MMP and ocular cicatricial pemphigoid (OCP) sera recognize β4 integrin subunit, oral pemphigoid sera recognize α6 integrin subunit, and anti-epiligrin cicatricial pemphigoid sera recognize laminin...

Full description

Saved in:
Bibliographic Details
Published inJournal of investigative dermatology Vol. 126; no. 12; pp. 2631 - 2636
Main Authors Rashid, Khwaja A., Gürcan, Hakan M., Razzaque Ahmed, A.
Format Journal Article
LanguageEnglish
Published Danvers, MA Elsevier Inc 01.12.2006
Nature Publishing
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mucous membrane pemphigoid (MMP) has several subsets based on target antigens recognized by their sera. MMP and ocular cicatricial pemphigoid (OCP) sera recognize β4 integrin subunit, oral pemphigoid sera recognize α6 integrin subunit, and anti-epiligrin cicatricial pemphigoid sera recognize laminin 5. Our aim is to determine if autoantibodies in the sera of patients with MMP, OCP, and oral pemphigoid (OP) recognize only their target antigens, and to see if this specificity is maintained throughout the clinical course. An immunoblot assay using bovine gingival lysate was used as substrate. Fifteen MMP patients, eight with OCP, and 15 OP patients were studied before therapy and at multiple intervals during the clinical course. Absorption and blocking studies were performed to determine binding specificity. Sera of patients with MMP and OCP recognize only β4 integrin subunit, and sera of OP patients recognize α6 integrin throughout the clinical course. The sera of patients in the subsets of MMP described in this report show adherence and selectivity to target antigen during the entire clinical course, without crossover, interaction, or change. Hence, these subsets of MMP provide an excellent model to study clinical correlation with antigen and antibody specificity, in autoimmunity.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-202X
1523-1747
DOI:10.1038/sj.jid.5700465